Nourish Secures $70M Series B to Expand AI-Powered Nutrition Care Platform

Nourish, the leading provider of nutrition counseling in the United States, has announced a $70 million Series B funding round, bringing its total funding to $115 million. The investment was led by J.P. Morgan Private Capital's Growth Equity Partners, with participation from Thrive Capital, Index Ventures, Y Combinator, Maverick Ventures, BoxGroup, Atomico, G Squared, and Pinegrove.

The company plans to use this capital to accelerate product development, expand its network of Registered Dietitians (RDs), and strengthen strategic partnerships across the healthcare ecosystem while growing its team across all departments.

Founded just over three years ago by three friends who experienced the benefits of dietary interventions for their own chronic conditions, Nourish has rapidly scaled to serve hundreds of thousands of patients nationwide. The company now employs over 3,000 W-2 RDs—the largest such network in the country—and operates in all 50 states.

"We built Nourish to make healthcare radically better for millions of Americans — it's the care we wanted ourselves during our own patient journeys," said Aidan Dewar, co-founder and CEO. "We wanted to build a patient-friendly healthcare system with lifestyle change and nutrition as a first-line treatment, not an afterthought. We're combining cutting-edge AI with the best RD team in the country to deliver personalized care that actually works, at a fraction of the cost of traditional medicine. It is not only more effective and accessible, but also more human."

Nourish addresses a critical healthcare gap: while 60% of Americans live with at least one chronic condition and 40% have two or more, less than 1% of eligible individuals utilize their covered nutrition benefits due to awareness and access limitations. The company partners with national commercial, Medicare, and Medicaid plans, covering hundreds of millions of lives, with 94% of patients paying nothing out of pocket.

Early clinical results are promising. Data shows patients using GLP-1 medications like Ozempic in conjunction with Nourish's RD services lost 33% more weight while reporting better medication adherence and fewer side effects.

The company's technology platform includes AI meal tracking, wearable and lab integrations, recipes, and other patient support tools. For dietitians, Nourish provides an AI copilot that automates administrative tasks and surfaces clinical insights, allowing them to focus on patient care.

Sam Perkins, co-founder, President and COO of Nourish, emphasized the economic implications: "Our healthcare system is at an inflection point, with chronic disease rates and costs rising to unsustainable levels. Payers are under growing pressure to find scalable solutions that actually work. Nourish meets this need by addressing the root cause of chronic disease — giving payers a powerful new lever to improve outcomes, bend the cost curve, and deliver a care experience members love."

Click here for the original news story.